Allergan: Breast Implant Cancer Lawsuit

Event News

Researcher: Ariana Arce​

Researcher: Ariana Arce​

Journalist: Aaron Vivanco

Journalist: Aaron Vivanco

Editor: Daniela Polo

Editor: Daniela Polo

Contact Us

We will review your case so that we can help you become a part of the lawsuit to hold the company accountable.

Allergan: Breast Implant Cancer Lawsuit

An uncommon form of cancer known as breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) has been linked to textured breast implants that Allergan’s affiliates have manufactured, marketed, and sold. 

Women, then started filing lawsuits because they claim that when they purchased their implants from Allergan or its affiliates, they were not informed about the cancer risk.

Woman deciding to have a allergan breast implant.

Allergan Breast Implant Recall

In July 2019, Allergan issued a voluntary medical device recall of some specific batches of its Natrelle Biocell textured implants, due to an uncommon incidence of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL).This included approximately 250,000 cosmetic and reconstructive implants manufactured between 2014 – 2019 throughout the United States. 

In order to reduce the risk of patients being exposed to recalled devices or any other unanticipated risks from these products, Allergan is now providing patients with an implant exchange program. However, before making a choice, anyone thinking about getting a new implant should be aware of this unexpected risk.

Which Products Were on the Allergan Implant Recall List?

The recall affects different types of Allergan Natrelle breast implant models: 

  • Natrelle Saline breast implant.
  • Natrelle and McGhan 410 breast implant.
  • Natrelle and McGhan 410 Soft Touch breast implant.
  • Natrelle 510 Dual-Gel.
  • Natrelle INSPIRA breast implants.
  • Natrelle and McGhan Round Gel Implants.
  • Natrelle Komuro breast implants.
  • Natrelle Ritz Princess breast implant.
  • Natrelle 150 Full Height and Short Height double lumen implants
  • Natrelle 133 tissue expanders with and without suture tabs.
  • Natrelle 133 Plus tissue expander.

*It is important to mention that not all styles of the products mentioned above have been recalled, you can read the list with the styles and models here.

Lawsuit Updates


As of May, there were 1,129 cases pending in the New Jersey federal court. 


Product liability and securities-law plaintiffs alleged that Allergen failed to disclose a higher incidence of BIA-ALCL in patients who received their textured breast implants compared to other manufacturers.

The court determined that Allergan was not obligated to disclose the higher incidence rate of its textured breast implants compared to those of other manufacturers. Therefore, both the plaintiffs in the Textured Breast Implant MDL and Securities Litigation case cannot establish that their illnesses or injuries were caused by implants from a particular company.


In February, Allergan presented a motion to dismiss all plaintiffs’ claims on the issue of federal preemption.

A Specific Case of Allergan Breast Implant Lawsuit

The Allergan breast implant lawsuit filed in the Netherlands was brought forth by the Bureau Clara Wichmann, a women’s rights organization, seeking approximately €900 million in damages for about 5,000 women who unknowingly received potentially harmful implants.

The lawsuit seeks damages to cover both the removal of dangerous breast implants and reconstruction surgery, since most health insurance providers do not typically cover these processes unless it is deemed medically necessary, something that the women’s group finds to occur too late.

Link between Breast Implants and Cancer

BIA-ALCL is an extremely rare type of cancer that can occur in patients with breast implants. Although it is quite rare, BIA-ALCL has been associated with certain types of breast implants, and if left untreated, it can be fatal. 

In most cases, one of the breasts will appear larger than the other or look completely different in shape. These changes generally appear within a year after receiving the implant, or it may even take until 8 years for symptoms to occur.

Not only do changes in size and shape indicate the possibility of BIA-ALCL but some other associated symptoms may include pain around the implant area.

If you or someone you love has received an implant and experienced any of these symptoms. It is recommended that you visit your healthcare provider to get examined. In addition to breast imaging tests, tissue sampling from around the breast implants will determine the formation of BIA-ALCL.

Additionally, you can contact our legal advisor service free of charge to asses your claim and check your eligibility.